Q90871
Gene name |
IRF8 (ICSBP) |
Protein name |
Interferon regulatory factor 8 |
Names |
IRF-8, Interferon consensus sequence-binding protein, ICSBP |
Species |
Gallus gallus (Chicken) |
KEGG Pathway |
gga:396385 |
EC number |
|
Protein Class |
|

Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

1 structures for Q90871
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q90871-F1 | Predicted | AlphaFoldDB |
19 variants for Q90871
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs736721114 | 15 | I>V | No | Ensembl | |
rs735932666 | 16 | E>G | No | Ensembl | |
rs732122683 | 95 | V>G | No | Ensembl | |
rs737253403 | 126 | N>D | No | Ensembl | |
rs733746104 | 128 | S>G | No | Ensembl | |
rs731447895 | 156 | Y>S | No | Ensembl | |
rs740195301 | 163 | S>R | No | Ensembl | |
rs734579545 | 183 | Q>R | No | Ensembl | |
rs732408874 | 216 | R>G | No | Ensembl | |
rs741213245 | 217 | L>V | No | Ensembl | |
rs733606037 | 218 | V>G | No | Ensembl | |
rs732976633 | 224 | S>P | No | Ensembl | |
rs737645021 | 233 | L>P | No | Ensembl | |
rs315813555 | 245 | T>I | No | Ensembl | |
rs735335032 | 299 | V>G | No | Ensembl | |
rs736037017 | 371 | V>G | No | Ensembl | |
rs739486659 | 372 | E>G | No | Ensembl | |
rs735280668 | 399 | E>G | No | Ensembl | |
rs739923958 | 402 | Y>D | No | Ensembl |
No associated diseases with Q90871
3 GO annotations of cellular component
Name | Definition |
---|---|
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
3 GO annotations of molecular function
Name | Definition |
---|---|
DNA-binding transcription factor activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II. |
DNA-binding transcription repressor activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that represses or decreases the transcription of specific gene sets transcribed by RNA polymerase II. |
RNA polymerase II cis-regulatory region sequence-specific DNA binding | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. |
18 GO annotations of biological process
Name | Definition |
---|---|
cellular response to interferon-gamma | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far. |
cellular response to lipopolysaccharide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
defense response to bacterium | Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism. |
defense response to protozoan | Reactions triggered in response to the presence of a protozoan that act to protect the cell or organism. |
dendritic cell differentiation | The process in which a precursor cell type acquires the specialized features of a dendritic cell. A dendritic cell is a leukocyte of dendritic lineage specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation. |
follicular B cell differentiation | The process in which a B cell in the spleen acquires the specialized features of a follicular B cell. Follicular B cells are major population of mature recirculating B cells in the spleen and are located in the B-cell follicle region. |
germinal center B cell differentiation | The process in which a B cell in the spleen acquires the specialized features of a germinal center B cell. Germinal center B cells are rapidly cycling B cells which have downregulated IgD expression and exhibit high levels of binding by peanut agglutinin (PNA). |
immune response | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
immune system process | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
myeloid cell differentiation | The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte, megakaryocyte, thrombocyte, or erythrocyte lineages. |
negative regulation of transcription by RNA polymerase II | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. |
phagocytosis | A vesicle-mediated transport process that results in the engulfment of external particulate material by phagocytes and their delivery to the lysosome. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles. |
plasmacytoid dendritic cell differentiation | The process in which a relatively unspecialized hemopoietic precursor cell acquires the specialized features of a plasmacytoid dendritic cell. |
positive regulation of interferon-gamma production | Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. |
positive regulation of interleukin-12 production | Any process that activates or increases the frequency, rate, or extent of interleukin-12 production. |
positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
regulation of transcription by RNA polymerase II | Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. |
regulation of type I interferon production | Any process that modulates the frequency, rate, or extent of interferon type I production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families. |
4 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q90643 | IRF3 | Interferon regulatory factor 3 | Gallus gallus (Chicken) | SS |
Q98925 | IRF2 | Interferon regulatory factor 2 | Gallus gallus (Chicken) | PR |
Q02556 | IRF8 | Interferon regulatory factor 8 | Homo sapiens (Human) | PR |
P23611 | Irf8 | Interferon regulatory factor 8 | Mus musculus (Mouse) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MCDRNGGRRL | RQWLIEQIDS | EQYPGLIWEN | EEKTMFRIPW | KHAGKQDYNQ | EVDASIFKAW |
70 | 80 | 90 | 100 | 110 | 120 |
AVFKGKFKEG | DKAEPATWKT | RLRCALNKSP | DFEEVTDRSQ | LDISEPYKVY | RIVPEEEQKC |
130 | 140 | 150 | 160 | 170 | 180 |
KIGVGNGSSL | TDVGDMDCSP | SAIDDLMKEP | PCVDEYLGII | KRSPSPPQET | CRNPPIPDWW |
190 | 200 | 210 | 220 | 230 | 240 |
MQQPSPSLPL | VNGYTGYEQH | HSGYSQMVIT | FFYSGRLVGH | ITTSYPEGCR | LSLSQPSNHG |
250 | 260 | 270 | 280 | 290 | 300 |
EKLYTPDSLE | HVRFPSAEAI | QNDRQKQITK | KLFGHLERGV | LLHSNKQGIF | IKRLCQGRVF |
310 | 320 | 330 | 340 | 350 | 360 |
WSGNTVVYKD | RPSKLDRDEV | VKIFDTNLFF | RELQQYYNNQ | GRFPDSRVML | CFGEEFPDTV |
370 | 380 | 390 | 400 | 410 | 420 |
PLRCKLILVQ | VEQLCVRQVM | EEAGKTCSSP | MLPDDVQQEQ | VYRIFQDICG | PHQRPLFREN |
QQIAV |